Open session of the standing technical committee of the EUFMD- 2004

Page 400

Appendix 62 OIE standards and recommended procedures for Foot and Mouth Disease (FMD)* Alejandro Schudel, Head of the Scientific and Technical Department, World Organization for Animal Health (OIE), 12 rue de Prony, 75017, Paris, France (a.schudel@oie.int) Preventing the spread of disease through international trade is one of the primary objectives of the World Organisation for Animal Health (OIE). This is accomplished by establishing international standards and guidelines that facilitate trade while minimising the risk of introducing diseases such as Foot and Mouth Disease (FMD). The OIE Standards are contained in the Terrestrial Animal Health Code (the Terrestrial Code) and the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (the Terrestrial Manual). Since 1995 the standards developed by the OIE were formalised as international standards by the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS) of the World Trade Organization (WTO). For this purpose the OIE has developed international standards to minimise the risk of the spread of FMD though international trade. These standards include: procedures for surveillance and prompt reporting of FMD outbreaks; requirements that should be met for a country or zone to be defined as free from FMD with vaccination or without vaccination; recommendations for the safe importation of animals, products, semen, and embryos into an FMD free country or zone; guidelines for surveillance for FMD, and the general provisions that countries should meet to reduce the risk of spread of FMD through trade. The Terrestrial Manual describes in detail the various tests and vaccines for FMD diagnosis and control. It provides a list of prescribed tests; these are tests that are required by the OIE Terrestrial Code for the international movement of animals and animal products and are considered optimal for determining the health status of animals. During the OIE 71st and 72nd General Session, the International Committee approved a new criteria for OIE listed diseases (international spread, significant spread within native populations, zoonotic potential, emerging disease), notification and epidemiological information , a resolution for the adoption of a new procedure for Validation and Certification of Diagnostic assays (Re. XXIX/71st. Gen. Ses.), introduction of the concept of freedom from FMD virus circulation, new standards for FMD vaccines (potency, purity) and FMD diagnostic laboratories, and important advances in the validation of the NSP index test for bovines. Finally the OIE participated in the June meeting of the United Nations Sub-Committee of Experts on the transport of Dangerous Goods (UNSCETDG) in Geneva and presented a document with the amendments to be incorporated in the 2005-2006 ICAO Technical Instructions.

391


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.